International Biophysics Corporation has sold its AffloVest respiratory therapy business to Tactile Systems Technology
Client – International Biophysics Corporation
Innovative, disruptive medical devices and technologies that improve treatment therapies and patient outcomes.
Counterparty – Tactile Systems Technology
Innovative portable, wearable airway clearance device that treats patients with chronic respiratory disorders.
The Northborne Partners team has been a trusted advisor to IBC since the early days of AffloVest. Ken Higgins and Scott Theisen proved to be invaluable partners, both in positioning us for a successful transaction and throughout transaction negotiations and due diligence. They were aggressive advocates for IBC’s interests, and I am thrilled with the result.David Shockley Chief Executive Officer and Founder of IBC